Baldini E, Lunghi A, Cortesi E, Turci D, et al. Immune-related adverse events correlate with clinical outcomes in NSCLC patients treated with nivolumab: The Italian NSCLC expanded access program. Lung Cancer 2020;140:59-64.
PMID: 31881412